Research Article
Neutrophil-Lymphocyte Ratio in Small Renal Masses
Table 1
Baseline characteristics for 1001 patients with renal masses ≤4 cm. Values are expressed as mean (SD), median (IQR), or frequency (percent).
| | Age at surgery, median (IQR) | 59.9 (51.7, 68.3) | | Gender | | | Male (%) | 619 (61.8%) | | Female (%) | 382 (38.2%) | | Race | | | Caucasian (%) | 892 (89.1%) | | African American (%) | 47 (4.7%) | | Other (%) | 62 (6.2%) | | ASA score | | | I-II (%) | 523 (52.2%) | | III-IV (%) | 478 (47.8%) | | Preoperative Crea, median | 1.1 (0.9, 1.2) | | Preoperative eGFR mL/min/1.73 m2, median | 69.6 (58.7, 82.3) | | <60 | 278 (27.8%) | | ≥60 | 723 (72.2%) | | Surgical procedure | | | Partial (%) | 984 (98.3%) | | Radical (%) | 17 (1.7%) | | Side of procedure | | | Right (%) | 492 (49.2%) | | Left (%) | 509 (50.8%) | | Pathology | | | Benign (%) | 202 (20.2%) | | Oncocytoma (%) | 149 (14.9%) | | Angiomyolipoma (%) | 31 (3.1%) | | Other benign (%) | 22 (2.2%) | | Malignant (%) | 799 (79.8%) | | Conventional RCC (%) | 538 (53.7%) | | Papillary RCC (%) | 118 (11.8%) | | Chromophobe RCC (%) | 77 (7.7%) | | Cystic RCC (%) | 43 (4.3%) | | Unclassified RCC (%) | 11 (1.1%) | | Other malignant (%) | 12 (1.2%) |
|
|
